Reviewer: HAN Bao-hui, Literature Co-worker: LIU Si-yang. Efficacy Comparison for Adjuvant Erlotinib Versus Placebo in Patients with StageⅠ B~ⅢA Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 222-225. DOI: 10.12019/j.issn.1671-5144.2018.04.008
|
Citation:
|
Reviewer: HAN Bao-hui, Literature Co-worker: LIU Si-yang. Efficacy Comparison for Adjuvant Erlotinib Versus Placebo in Patients with StageⅠ B~ⅢA Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 222-225. DOI: 10.12019/j.issn.1671-5144.2018.04.008
|
Reviewer: HAN Bao-hui, Literature Co-worker: LIU Si-yang. Efficacy Comparison for Adjuvant Erlotinib Versus Placebo in Patients with StageⅠ B~ⅢA Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 222-225. DOI: 10.12019/j.issn.1671-5144.2018.04.008
|
Citation:
|
Reviewer: HAN Bao-hui, Literature Co-worker: LIU Si-yang. Efficacy Comparison for Adjuvant Erlotinib Versus Placebo in Patients with StageⅠ B~ⅢA Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 222-225. DOI: 10.12019/j.issn.1671-5144.2018.04.008
|
DownLoad: